Literature DB >> 17613577

Overestimation of stability limits leads to a high frequency of falls in patients with Parkinson's disease.

Noriyuki Kamata1, Yoshimi Matsuo, Toshihiko Yoneda, Hideki Shinohara, Satoru Inoue, Kazuo Abe.   

Abstract

OBJECTIVES: To test a hypothesis that patients with Parkinson's disease may not notice discrepancies between their perceived and actual stability limits and cannot keep their centre of gravity within the stability region. SETTINGS: Outpatients with neurological disorders in rehabilitation service.
SUBJECTS: Twenty-one patients with Parkinson's disease (11 men, 10 women; mean duration 5.9 +/- 3.9 years) and age- and sex-matched healthy volunteers were recruited.
METHODS: Each subject's right arm length was subtracted from the distance between the right acromion and the perceived reachable boundary. This was called 'perceived reach'. The figure given by subtracting the right arm length from the maximum forward reach length measured by the Functional Reach Test was named 'actual reach', and is an index of actual stability limits in each subject. The difference between actual and perceived stability limits (DAP) is given by actual reach minus perceived reach. The motor score of the Unified Parkinson's Disease Rating Scale were used to evaluate disease severity.
RESULTS: The mean DAP for the Parkinson's disease group was negative (-1.8 +/- 5.7 cm) and significantly different from that of controls (3.3 +/- 9.2 cm) (P < 0.05). In Parkinson's disease, DAP was significantly correlated with the Unified Parkinson's Disease Rating Scale score (correlation coefficient = -0.39, P < 0.05).
CONCLUSIONS: These results indicated that patients with Parkinson's disease overestimated their stability limits, which may result in falls. In addition, the results demonstrate that patients with Parkinson's disease develop overestimation of stability limits in parallel with their disease progression.

Entities:  

Mesh:

Year:  2007        PMID: 17613577     DOI: 10.1177/0269215507073346

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  8 in total

1.  Fluorometric assay for N-acetylprocainamide.

Authors:  E Matusik; T P Gibson
Journal:  Clin Chem       Date:  1975-12       Impact factor: 8.327

2.  Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls.

Authors:  Sandra E Hasmann; Daniela Berg; Markus A Hobert; David Weiss; Ulrich Lindemann; Johannes Streffer; Inga Liepelt-Scarfone; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2014-10-24       Impact factor: 5.750

3.  The Cognition of Maximal Reach Distance in Parkinson's Disease.

Authors:  Satoru Otsuki; Masanori Nagaoka
Journal:  Parkinsons Dis       Date:  2016-08-15

4.  Motor Function Relating to the Accuracy of Self-Overestimation Error in Community-Dwelling Older Adults.

Authors:  Tsubasa Kawasaki; Ryosuke Tozawa
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

5.  In the elderly, failure to update internal models leads to over-optimistic predictions about upcoming actions.

Authors:  Gilles Lafargue; Myriam Noël; Marion Luyat
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

6.  Clinical correlates of awareness for balance, function, and memory: evidence for the modality specificity of awareness.

Authors:  Megan E O'Connell; Vanina Dal Bello-Haas; Margaret Crossley; Debra Morgan
Journal:  J Aging Res       Date:  2014-01-16

7.  Motor planning error in Parkinson's disease and its clinical correlates.

Authors:  Tsubasa Kawasaki; Kyohei Mikami; Tsutomu Kamo; Ryoma Aoki; Rumiko Ishiguro; Hiroshi Nakamura; Ryosuke Tozawa; Nao Asada; Yukinobu Hiiragi; Yoichi Yamada; Masahiro Hirano; Kazuko Katsuki
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

8.  Relationship between Motor Estimation Error and Physical Function in Patients with Parkinson's Disease.

Authors:  Katsuya Sakai; Tsubasa Kawasaki; Yumi Ikeda; Keita Tominaga; Kohei Kurihara
Journal:  Medicines (Basel)       Date:  2020-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.